BSX
Price
$99.40
Change
+$0.06 (+0.06%)
Updated
Jun 11 closing price
Capitalization
100.1B
41 days until earnings call
MYO
Price
$2.86
Change
-$0.02 (-0.69%)
Updated
Jun 11 closing price
Capitalization
93.15M
61 days until earnings call
Interact to see
Advertisement

BSX vs MYO

Header iconBSX vs MYO Comparison
Open Charts BSX vs MYOBanner chart's image
Boston Scientific
Price$99.40
Change+$0.06 (+0.06%)
Volume$8.45M
Capitalization100.1B
Myomo
Price$2.86
Change-$0.02 (-0.69%)
Volume$281.84K
Capitalization93.15M
BSX vs MYO Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. MYO commentary
Jun 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongBuy and MYO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 12, 2025
Stock price -- (BSX: $99.34 vs. MYO: $2.88)
Brand notoriety: BSX: Notable vs. MYO: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 109% vs. MYO: 60%
Market capitalization -- BSX: $100.1B vs. MYO: $93.15M
BSX [@Medical Specialties] is valued at $100.1B. MYO’s [@Medical Specialties] market capitalization is $93.15M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileMYO’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • MYO’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than MYO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while MYO’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • MYO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BSX is a better buy in the short-term than MYO.

Price Growth

BSX (@Medical Specialties) experienced а -3.65% price change this week, while MYO (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.36%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was +2.47%.

Reported Earning Dates

BSX is expected to report earnings on Jul 23, 2025.

MYO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than MYO($93.2M). BSX YTD gains are higher at: 11.218 vs. MYO (-55.279). BSX has higher annual earnings (EBITDA): 3.45B vs. MYO (-7.71M). BSX has more cash in the bank: 865M vs. MYO (8.87M). MYO has less debt than BSX: MYO (601K) vs BSX (9.49B). BSX has higher revenues than MYO: BSX (14.2B) vs MYO (19.2M).
BSXMYOBSX / MYO
Capitalization100B93.2M107,296%
EBITDA3.45B-7.71M-44,673%
Gain YTD11.218-55.279-20%
P/E Ratio63.64N/A-
Revenue14.2B19.2M73,958%
Total Cash865M8.87M9,756%
Total Debt9.49B601K1,579,368%
FUNDAMENTALS RATINGS
BSX vs MYO: Fundamental Ratings
BSX
MYO
OUTLOOK RATING
1..100
6652
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
5100
SMR RATING
1..100
7297
PRICE GROWTH RATING
1..100
2493
P/E GROWTH RATING
1..100
39100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MYO's Valuation (44) in the Medical Distributors industry is somewhat better than the same rating for BSX (85) in the Medical Specialties industry. This means that MYO’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (5) in the Medical Specialties industry is significantly better than the same rating for MYO (100) in the Medical Distributors industry. This means that BSX’s stock grew significantly faster than MYO’s over the last 12 months.

BSX's SMR Rating (72) in the Medical Specialties industry is in the same range as MYO (97) in the Medical Distributors industry. This means that BSX’s stock grew similarly to MYO’s over the last 12 months.

BSX's Price Growth Rating (24) in the Medical Specialties industry is significantly better than the same rating for MYO (93) in the Medical Distributors industry. This means that BSX’s stock grew significantly faster than MYO’s over the last 12 months.

BSX's P/E Growth Rating (39) in the Medical Specialties industry is somewhat better than the same rating for MYO (100) in the Medical Distributors industry. This means that BSX’s stock grew somewhat faster than MYO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXMYO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
63%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGLCF0.180.01
+4.65%
Cassiar Gold Corp.
TUWOY0.08N/A
+0.30%
Tullow Oil Plc.
FRCOY33.61-0.28
-0.83%
Fast Retailing Co. Ltd.
HVRRY52.84-1.25
-2.31%
Hannover Re
PTBRY14.09-1.20
-7.85%
PT Bank Negara Indonesia TBK

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-0.70%
ISRG - BSX
73%
Closely correlated
+0.66%
SYK - BSX
69%
Closely correlated
+0.72%
MMSI - BSX
63%
Loosely correlated
+0.35%
NTRA - BSX
50%
Loosely correlated
+0.63%
ALC - BSX
48%
Loosely correlated
+1.68%
More

MYO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYO has been loosely correlated with VMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MYO jumps, then VMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
-3.03%
VMD - MYO
36%
Loosely correlated
+0.44%
MXCT - MYO
35%
Loosely correlated
+5.96%
TWST - MYO
31%
Poorly correlated
+3.27%
BVS - MYO
31%
Poorly correlated
+2.08%
BSX - MYO
28%
Poorly correlated
-0.70%
More